Schedule 13G ownership disclosure

Cardiff Oncology Inc

Security class unavailable · CUSIP: 14147L108

Event date: 2020-10-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-121396
Form type
SC 13G
Filer
Cardiff Oncology, Inc.
CIK
CIK 1213037
Filed
Nov 04, 2020
Reporting period
Oct 08, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub